Document Detail


Arginine supplementation prevents necrotizing enterocolitis in the premature infant.
MedLine Citation:
PMID:  12006956     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To determine whether supplementation with L -arginine reduces the incidence of all stages of necrotizing enterocolitis (NEC) in premature infants with birth weight < or =1250 g and gestational age < or =32 weeks. STUDY DESIGN: In a randomized, double-blind, placebo-controlled study, 152 premature infants were prospectively, randomly assigned to receive either supplemental L -arginine (1.5 mmol/kg per day; n =75 [group A]) or placebo (control group; n = 77 [group B]) with oral feeds/parenteral nutrition during the first 28 days of life. Nutrient intake, plasma ammonia, arginine, and amino acid concentrations were measured in all infants at days 3, 14, and 28 and at the time of diagnosis of NEC. RESULTS: NEC developed in 5 infants in group A compared with 21 infants in group B (P <.001). Arginine intake and plasma arginine concentrations were similar in both groups at study entry and (as expected) increased in group A at days 14 and 28. Plasma arginine concentrations were lower in both groups at time of diagnosis of NEC. No significant differences in maternal and neonatal demographics, nutrient intake, plasma ammonia and total and essential amino acid concentrations were present between the two groups. CONCLUSIONS: Arginine supplementation (1.5 mmol/kg per day) in premature infants reduces the incidence of all stages of NEC.
Authors:
Harish J Amin; Samuel A Zamora; Douglas D McMillan; Gordon H Fick; J Decker Butzner; Howard G Parsons; R Brent Scott
Related Documents :
10402286 - Snare-assisted vascular access: a new technique.
8040776 - Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis ...
10852186 - Growth and neurodevelopmental outcome of very low birthweight infants with necrotizing ...
3723306 - Long-term follow-up after surgical management of necrotizing enterocolitis: sixty-three...
12478626 - Incident of intense aggression by chimpanzees against an infant from another group in m...
8462236 - High-dose urokinase therapy in newborn infants with major vessel thrombosis.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  140     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-05-13     Completed Date:  2002-06-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  425-31     Citation Subset:  AIM; IM    
Affiliation:
Division of Neonatology, Department of Pediatrics, The University of Calgary, Calgary, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arginine / blood,  therapeutic use*
Canada / epidemiology
Dietary Supplements*
Double-Blind Method
Enterocolitis, Necrotizing / blood,  epidemiology,  therapy*
Female
Gestational Age
Glutamine / blood
Humans
Incidence
Infant Welfare
Infant, Newborn
Infant, Premature*
Infant, Very Low Birth Weight
Male
Severity of Illness Index
Treatment Outcome
Chemical
Reg. No./Substance:
56-85-9/Glutamine; 74-79-3/Arginine
Comments/Corrections
Comment In:
J Pediatr. 2002 Apr;140(4):389-91   [PMID:  12006949 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transient orthostatic hypotension is common in adolescents.
Next Document:  A national point-prevalence survey of pediatric intensive care unit-acquired infections in the Unite...